20376-34-5Relevant academic research and scientific papers
Triazine compound as well as preparation method and application thereof
-
Paragraph 0027; 0028; 0029; 0055; 0056; 0057, (2017/11/30)
The invention provides a triazine compound shown as a chemical formula (I) and a preparation method thereof as well as an application of the triazine compound in preparing drugs for treating central nervous system diseases. In the formula, R1 is selected
N4-Phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-d iamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease
Huang, Wenwei,Zheng, Wei,Urban, Daniel J.,Inglese, James,Sidransky, Ellen,Austin, Christopher P.,Thomas, Craig J.
, p. 5783 - 5789 (2008/02/13)
A series of 1,3,5-triazine-2,4,6-triamines were prepared and analyzed as inhibitors of glucocerebrosidase. Synthesis, structure activity relationships and the selectivity of chosen analogues against related sugar hydrolases enzymes are described.
Triaminotriazine DNA helicase inhibitors with antibacterial activity
McKay, Geoffrey A.,Reddy, Ranga,Arhin, Francis,Belley, Adam,Lehoux, Dario,Moeck, Greg,Sarmiento, Ingrid,Parr, Thomas R.,Gros, Philippe,Pelletier, Jerry,Far, Adel Rafai
, p. 1286 - 1290 (2007/10/03)
Screening of a chemical library in a DNA helicase assay involving the Pseudomonas aeruginosa DnaB helicase provided a triaminotriazine inhibitor with good antibacterial activity but associated cytotoxicity toward mammalian cells. Synthesis of analogs provided a few inhibitors that retained antibacterial activity and demonstrated a significant reduction in cytotoxicity. The impact of serum and initial investigations toward a mode of action highlight several features of this class of compounds as antibacterials.
